[go: up one dir, main page]

SV2003000995A - Nuevas arilsulfonamidas como agentes antivirales ref. lea35214-sv - Google Patents

Nuevas arilsulfonamidas como agentes antivirales ref. lea35214-sv

Info

Publication number
SV2003000995A
SV2003000995A SV2002000995A SV2002000995A SV2003000995A SV 2003000995 A SV2003000995 A SV 2003000995A SV 2002000995 A SV2002000995 A SV 2002000995A SV 2002000995 A SV2002000995 A SV 2002000995A SV 2003000995 A SV2003000995 A SV 2003000995A
Authority
SV
El Salvador
Prior art keywords
new
antiviral agents
lea35214
arilsulfonamids
agents ref
Prior art date
Application number
SV2002000995A
Other languages
English (en)
Inventor
Wolfgang Bender
Peter Eckenberg
Kerstin Henninger
Jorg Keldenich
Siegfried Raddatz
Gunter Schmidt
Tobias Wunberg
Armin Kern
Jurgen Reefschlager
Holger Zimmermann
Franz Zumpe
Martin Radtke
Sabine Hallenberger
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of SV2003000995A publication Critical patent/SV2003000995A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

NUEVAS ARILSULFONAMIDAS COMO AGENTES ANTIVIRALESLA PRESENTE INVENCIÓN SE REFIERE A NUEVAS SULFONAMIDAS DE FÓRMULA GENERAL (I) (VER FORMULA), EN LA QUE LOS SUSTITUYENTES R1, R2, R3 Y R4, ASÍ COMO A Y X TIENEN LOS SIGNIFICADOS CITADOS, ASÍ COMO A PROCEDIMIENTOS PARA SU PREPARACIÓN Y A SU USO COMO AGENTES ANTIVIRALES, ESPECIALMENTE FRENTE A CITOMEGALOVIRUS.
SV2002000995A 2001-04-19 2002-04-18 Nuevas arilsulfonamidas como agentes antivirales ref. lea35214-sv SV2003000995A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10119137 2001-04-19
DE10148598A DE10148598A1 (de) 2001-04-19 2001-10-02 Neue Arylsulfonamide als antivirale Mittel

Publications (1)

Publication Number Publication Date
SV2003000995A true SV2003000995A (es) 2003-03-18

Family

ID=7681939

Family Applications (1)

Application Number Title Priority Date Filing Date
SV2002000995A SV2003000995A (es) 2001-04-19 2002-04-18 Nuevas arilsulfonamidas como agentes antivirales ref. lea35214-sv

Country Status (9)

Country Link
KR (1) KR20030088509A (es)
AR (1) AR034309A1 (es)
CO (1) CO5540388A2 (es)
DE (1) DE10148598A1 (es)
EC (1) ECSP034813A (es)
GT (1) GT200200075A (es)
PE (1) PE20021061A1 (es)
SV (1) SV2003000995A (es)
ZA (1) ZA200307892B (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7482366B2 (en) * 2001-12-21 2009-01-27 X-Ceptor Therapeutics, Inc. Modulators of LXR
AU2003262831A1 (en) 2002-08-23 2004-03-11 Rigel Pharmaceuticals, Inc. Pyridyl substituted heterocycles useful for treating or preventing hcv infection
EP1581213A4 (en) * 2002-12-18 2008-11-19 Cytovia Inc 3,5-DISUBSTITUTED 1,2,4-OXADIAZOLE AND ANALOGUE TO ACTIVATE CASPASE AND INTRODUCTION OF APOPTOSIS AND THEIR USE
DE10300109A1 (de) * 2003-01-07 2004-07-15 Bayer Healthcare Ag Methode zur Inhibition der Replikation von Herpesviren
EP1620412A2 (en) 2003-05-02 2006-02-01 Rigel Pharmaceuticals, Inc. Heterocyclic compounds and hydro isomers thereof
US8580842B2 (en) 2003-09-30 2013-11-12 Abbott Gmbh & Co. Kg Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing them
WO2005049065A2 (en) 2003-11-19 2005-06-02 Rigel Pharmaceuticals, Inc. Synergistic combinations of dihaloacetamide with interferon or ribavirin for treatment hcv infections
US7514434B2 (en) 2004-02-23 2009-04-07 Rigel Pharmaceuticals, Inc. Heterocyclic compounds having an oxadiazole moiety and hydro isomers thereof
EP1883633A2 (en) 2005-05-02 2008-02-06 Rigel Pharmaceuticals, Inc. Heterocyclic anti-viral compounds comprising metabolizable moieties and their uses
US8486979B2 (en) 2006-12-12 2013-07-16 Abbvie Inc. 1,2,4 oxadiazole compounds and methods of use thereof
UY30846A1 (es) 2006-12-30 2008-07-31 Abbott Gmbh & Amp Derivados de oxindol sustituidos, medicamentos que los comprenden y uso de los mismos
US20080255203A1 (en) * 2007-04-12 2008-10-16 Abbott Laboratories Heterocyclic compounds and their methods of use
WO2010009775A1 (de) 2007-12-07 2010-01-28 Abbott Gmbh & Co. Kg Carbamat-substituierte oxindol-derivate und ihre verwendung zur behandlung von vasopressin-abhängigen erkrankungen
ES2397125T3 (es) 2007-12-07 2013-03-04 Abbott Gmbh & Co. Kg Derivados de oxindol sustituidos con halógeno en la posición 5 y su uso para la producción de un medicamento para el tratamiento de enfermedades dependientes de la vasopresina
MX2010006204A (es) 2007-12-07 2011-03-16 Abbott Gmbh & Co Kg Derivados de oxindol 5,6-disubstituidos y el uso de los mismos para el tratamiento de enfermedades dependientes de la vasopresina.
CN101981027B (zh) 2007-12-07 2014-08-06 Abbvie德国有限责任两合公司 氨基甲基取代的羟吲哚衍生物及其用于治疗加压素依赖性疾病的用途
WO2010138600A2 (en) 2009-05-29 2010-12-02 Abbott Laboratories Pharmaceutical compositions for the treatment of pain

Also Published As

Publication number Publication date
CO5540388A2 (es) 2005-07-29
KR20030088509A (ko) 2003-11-19
GT200200075A (es) 2002-12-24
AR034309A1 (es) 2004-02-18
DE10148598A1 (de) 2002-10-24
ECSP034813A (es) 2003-12-01
ZA200307892B (en) 2004-10-11
PE20021061A1 (es) 2002-12-12

Similar Documents

Publication Publication Date Title
SV2003000995A (es) Nuevas arilsulfonamidas como agentes antivirales ref. lea35214-sv
ECSP066541A (es) Nuevos derivados de piridazin-3(2h)-ona
BRPI0411528A (pt) uso de isomalte como prebiótico
AR057325A1 (es) Sintesis de (s)-n-metilnaltrexona, composiciones farmaceuticas y usos
UY27263A1 (es) Nuevas arilsulfonamidas como agentes antivirales
PA8570901A1 (es) Derivados de acil-4-carboxifenilurea, procedimientos para su preparacion y su uso
UY28342A1 (es) Nuevos compuestos
ECSP045410A (es) Nuevos derivados de piridazin-3(2h)-ona
HN2002000300A (es) Nuevos derivados de piperazina
CR8824A (es) Derivados de 2-carbamida-4-feniltiazol, su preparacion y su aplicacion en terapeutica
UY29795A1 (es) Derivados de adenina, composiciones farmacéuticas que los contienen, procesos de preparación y aplicaciones
SV1999000118A (es) Nuevos derivados de pirazol substituidos ref. lea 33188-sv
PA8575601A1 (es) Procedimiento para su preparacion, medicamentos que comprenden estos compuestos y su uso
NO20070122L (no) Quinazolinonderivater anvendelige som vanilloidantagonister
ECSP055671A (es) Nuevas quinazolinonas espirocondensadas y su uso como inhibidores de la fosfodiesteresa
GT200500238A (es) Fenilaminotiazoles sustituidos y su uso
CR8451A (es) Uso de derivados de n-arilhidracina para combatir pestes
SV1999000006A (es) Nuevas sulfonamidas naftil- y anilido-substituidas ref. lea 32809-sv
AR027575A1 (es) Benzoilciclohexenonas substituidas
ECSP066304A (es) Compuestos
PA8557201A1 (es) Compuestos basicos lineales que tienen actividad antagonista de nk-2 y su formulaciones
CR8340A (es) Pirazolilcarboxanilidas n-sustituidas
SV2006002220A (es) Derivados de alquiliden-tetrahidronaftaleno, procedimiento para su preparacion y su uso como antiinflamatorios ref. p-sv-78.836/cd
DK1370513T3 (da) Æblesyreadditionssalte af terbinafin
ECSP056231A (es) Fluorbutenos nematicidas que contienen tiazolina

Legal Events

Date Code Title Description
FD Lapse